Fundraising Fox

Erica Barnell

Founder

Co-founder at Geneoscopy, Inc

St Louis, Missouri, United States

FoundedGeneoscopy, Inc

30 Under 30 2020 Β· Healthcare

About

Erica Barnell is the co-founder and Chief Medical Officer of Geneoscopy, a company developing RNA-based diagnostics for gastrointestinal conditions including colorectal cancer and inflammatory bowel disease. During her tenure, the company's ColoSense became the first FDA-approved RNA-based colorectal cancer screening test for average-risk patients, raised over $200 million in funding, established a CAP/CLIA laboratory, and partnered with Labcorp for commercialization. Barnell holds an MD and a PhD in bioinformatics from Washington University School of Medicine and has authored more than 30 peer-reviewed publications, four book chapters, and several patents.

Co-founder at Geneoscopy, Inc

Intro paths

β†’

In turn, Erica can intro founders to Geneoscopy, Inc's investors below.

Co-founders at Geneoscopy, Inc

ABAndrew Barnell
Andrew BarnellChief Executive Officer & Co-founder

Experience

  1. GeneoscopyChief Medical Officercurrent2017 β€” presentSt Louis, Missouri, United States
  2. Tel Aviv UniversityMedical Researcher2014Tel Aviv, Israel
  3. Barnes-Jewish HospitalResearch Technician2013 β€” 2014Saint Louis
  4. Cornell UniversityOrganic Chemistry Tutor2012 β€” 2013Tompkins County, New York, United States
  5. Cornell UniversityIntroductory Biology Teaching Assistant2011Tompkins County, New York, United States
  6. Washington University School of MedicineASPIRE Undergraduate Researcher2012Greater St. Louis
  7. Donald Danforth Plant Science CenterUndergraduate Researcher2011Greater St. Louis
  8. Cornell UniversityUndergraduate Researcher2010 β€” 2011Tompkins County, New York, United States
  9. Conde NastAssistant to the Editor2010New York City Metropolitan Area

Skills & more

Clinical Research8Laboratory11French to English4Business Development2Statistical Data Analysis2DNA sequencing6DNA extraction6Gel Electrophoresis17RNA isolation3SPSS4Genetic Engineering1Genetic Markers1
+10 morePCRVector CloningExpression CloningDNA microarrayResearchPublic SpeakingStatisticsData AnalysisSocial MediaDNA Extraction
  • High Complexity Clinical Laboratory Director (HCLD) β€” American Board of Bioanalysis (ABB)

From Erica's professional profile.

Frequently asked questions

Who is Erica Barnell?
Erica Barnell is the co-founder and Chief Medical Officer of Geneoscopy, a company developing RNA-based diagnostics for gastrointestinal conditions including colorectal cancer and inflammatory bowel disease. During her tenure, the company's ColoSense became the first FDA-approved RNA-based colorectal cancer screening test for average-risk patients, raised over $200 million in funding, established a CAP/CLIA laboratory, and partnered with Labcorp for commercialization. Barnell holds an MD and a PhD in bioinformatics from Washington University School of Medicine and has authored more than 30 peer-reviewed publications, four book chapters, and several patents.
Where does Erica Barnell work?
Erica Barnell is Co-founder of Geneoscopy, Inc.
What companies did Erica Barnell found?
Erica Barnell founded Geneoscopy, Inc.
Where did Erica Barnell go to school?
Erica Barnell studied at Washington University School of Medicine in St. Louis (MD/PhD, Medicine); Cornell University (Bachelor of Science (B.Sc.), Biological Sciences & Applied Economics and Management).

Same school

Shared employers